 which is why I wasn't surprised FDA advisory committee voted pretty strongly against MAPS having shown efficacy for their treatment suggestion. Yeah. So does this difficulty with finding a lack of a real control group, does that mean it's just impossible to get good data on MDMA therapy? Or is there another way to look at this from a research perspective?